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The coordinated development of the nervous system requires fidelity in the expression of
specific genes determining the different neural cell phenotypes. Stem cell fate decisions
during neurodevelopment are strictly correlated with their epigenetic status. The
epigenetic regulatory processes, such as DNA methylation and histone modifications
discussed in this review article, may impact both neural stem cell (NSC) self-renewal
and differentiation and thus play an important role in neurodevelopment. At the same
time, stem cell decisions regarding fate commitment and differentiation are highly
dependent on the temporospatial expression of specific genes contingent on the
developmental stage of the nervous system. An interplay between the above, as well
as basic cell processes, such as transcription regulation, DNA replication, cell cycle
regulation and DNA repair therefore determine the accuracy and function of neuronal
connections. This may significantly impact embryonic health and development as well
as cognitive processes such as neuroplasticity and memory formation later in the
adult.
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INTRODUCTION
The development of the nervous system is regulated by a multitude of intracellular molecular
and cellular signals interacting with the extracellular microenvironment in a temporal and spatial
manner. These signals induce expression of genes involved in lineage commitment, differentiation,
maturation, migration and cell survival. In addition, silencing of genes responsible for the
maintenance of stem cells in a pluripotent state and for cell fate decisions are important hallmarks
of neurodevelopment (Lilja et al., 2012). Neural stem cells (NSCs) are able to proliferate and
self-renew and also give rise to all neural lineage cells in the central nervous system (CNS): neurons,
astrocytes and oligodendrocytes (Altman, 1962; Gage, 2000).
After development is completed, NSCs are still present in the adult brain throughout its entire
lifetime in two neurogenic niches: the subventricular zone (SVZ) lining the lateral ventricles,
and the subgranular zone (SGZ), which is part of the dentate gyrus (DG) of the hippocampus
(Eriksson et al., 1998). It is well documented in pioneering (Hsieh and Gage, 2004) and more
recent studies that epigenetic alteration plays a crucial role in the maintenance of the resident
NSC multipotent state as well as in their differentiation process (Mohamed Ariff et al., 2012).
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The term ‘‘epigenetics’’ was coined by Conrad Waddington
(1905–1975) in 1942 to describe interactions between genotype
and the environment, which together shape the expressed
characteristic traits of an organism, defined as the phenotype
(Waddington, 1942). Different definitions of the term epigenetics
exist and a clear consensus is still lacking. The name epi-
(Greek: εpi í- over, above, outer)-genetics refers to exogenous
dynamic mechanisms which change gene expression without
changing the DNA sequence. Epigenetic changes can however
be inherited through subsequent cell divisions. Each cell
type has a unique gene expression profile (transcriptome)
and also a distinctive chromatin signature (Sha and Boyer,
2009). Interestingly, epigenetic changes are dependent on
environmental factors. It has been documented that maternal
behavior during pregnancy or prenatal stress may lead to
epigenetic alterations in the offspring (Wu et al., 2004; Morgan
and Bale, 2011).
Epigenetic mechanisms that control changes in gene
expression levels can be divided into three main groups: (i) DNA
methylation; (ii) histone and chromatin modifications, including
histone variants; and (iii) non-coding RNAs (ncRNAs) such
as long non-coding RNA (lncRNA) and small non-coding
RNAs (sncRNAs), including microRNAs (miRNAs); and small
interfering RNAs (siRNAs; Jenuwein and Allis, 2001; Sun et al.,
2008; Mohamed Ariff et al., 2012; Fenoglio et al., 2013).
This review article will focus on the regulation of DNA
methylation and two types of histone modification: methylation
and acetylation and their relevance to stem cell fate decisions
in neurodevelopmental processes. The epigenetic events
are considered to act in a switch-like mode (Hoffmann
et al., 2015), however the potential of the cell to undertake
developmental decisions, stemness/lineage commitment and
further differentiation is highly dependent on the activity of the
genes typical for the defined stage of development. A schematic
correlation of neurodevelopmental hierarchy of stem cells,
along with their epigenetic status is presented on Figure 1.
Developmental genes are referred to as being at an activated
(on), repressed (off) or bivalent (poised) stage. This is linked
to the pattern of DNA and histone permissive and inhibitory
epigenetic marks, which are further discussed in this review
article.
DNA METHYLATION AND ITS RELEVANCE
TO STEM CELLS AND
NEURODEVELOPMENT
DNA Methylation
DNA methylation is a crucial process in embryogenesis and
normal development and one of the most frequently investigated
epigenetic modifications. It is involved in regulation of gene
expression (Keshet et al., 1986), X-chromosome inactivation
(Heard et al., 1997), genomic imprinting (Li et al., 1993;
Denomme and Mann, 2013), regulation of chromatin structure
(Bernstein et al., 2007), transposon silencing (Walsh et al.,
1998) and control of telomere length (Gonzalo et al., 2006).
Methylation of cytosine at the C5 position is catalyzed by
various DNA methyltransferases (DNMTs), which catalyze
the transfer of a methyl group (-CH3), derived from the
S-adenosylmethionine (SAM; methyl donor) onto cytosine and,
as a result, lead to formation of 5-methylcytosine (5mC;
Cheng et al., 1993). There is also an alternative form of
DNA methylation; Kriaucionis and Heintz (2009) discovered
5-hydroxymethylcytosine (5hmC), an unusual DNA nucleotide
that occurs frequently in the mouse brain.
The DNA methylation pattern is established during
embryonic development by de novo DNMTs (DNMT3A
and DNMT3B supported by DNMT3L), while maintenance
of this pattern is linked with activity of the DNMT1 (Razin
and Szyf, 1984; Li and Zhao, 2008). Lister et al. (2009) suggest
that DNMT3A may be responsible for catalyzing cytosine
methylation at non-5′-C-phosphate-G-3′(CpG) sites.
An interesting fact is that in mammals the DNA of
mature sperm and egg is highly methylated compared with
somatic cells. However, the largest extent of this methylation
disappears during the preimplantation developmental stage
(genome wide demethylation). After implantation, the embryo
undergoes a de novo DNA methylation process (Reik et al.,
2001; Denomme and Mann, 2013). Furthermore, Dnmt1 or
Dnmt3a and Dnmt3b knockout mice die during mid-gestation
(Li et al., 1992; Okano et al., 1999; Ueda et al., 2006). There
are two mechanisms for the regulation of gene expression by
DNA methylation: (i) DNA methylation prevents the binding
of certain transcription factors, which blocks transcription;
and (ii) methylated CpG dinucleotides are recognized by a
family of proteins containing methyl-CpG-binding domain
(MBD) such as MBD1 and methyl CpG binding protein 2
(MeCP2), which actively block their binding sites and are
consequently responsible for gene inactivation (Li and Zhao,
2008; Sun et al., 2008). MBD-proteins can block transcription
alone or in cooperation with enzymes responsible for histone
modification (Nan et al., 1998). Interestingly, recent studies
have shown that actively transcribed genes have high levels
of gene body methylation (Lister et al., 2009; Wu et al.,
2010).
Regulation of DNA Methylation
Traditionally DNA methylation was considered as stable,
irreversible epigenetic modification. However, studies conducted
in recent years revealed methylation changes in postnatal brains
(Guo et al., 2011a).
It has been proposed that the demethylation process may
take place in two different ways; either active or passive. The
passive way is associated with suppression of DNMT1, while
active demethylation occurs enzymatically and is catalyzed by
TET1—tet methylcytosine dioxygenase 1 (5mC hydroxylase)
(Wu and Zhang, 2010; Guo et al., 2011b) involved in oxidative
reaction of 5mC to 5hmC transition.
The other mechanism, which is involved in active DNA
demethylation is associated with growth arrest and DNA-
damage-inducible alpha (GADD45A) protein. GADD45 proteins
are involved in many processes associated with cellular response
to stress. They have been implicated in cell-cycle control, DNA
repair and suppression of cell growth (Kaufmann et al., 2011).
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FIGURE 1 | Schematic representation of the correlation of the stem cells’ developmental hierarchy with their epigenetic status based on the balance
between inhibitory (DNA and H3K27 methylation) and permissive (H3K4 methylation) epigenetic marks.
High GADD45A expression is associated with global DNA
demethylation (Barreto et al., 2007). Gadd45 genes mediate
the repair-based DNA demethylation and may occur by three
mechanisms as described (Teperek-Tkacz et al., 2011; Niehrs
and Schäfer, 2012). Some authors have suggested that DNA
methylation patterns may be useful epigenetic markers in
characterizing different types of pluripotent and differentiated
cells (Watanabe et al., 2012). The basis for their assumptions is
the fact that there are different patterns of DNA methylation
in pluripotent stem cells, during their differentiation and in
terminally differentiated cells. It has been demonstrated that the
DNAmethylation profile undergoes dynamic changes during the
process of cell differentiation, particularly in HCP promoters
(promoters with high CpG content; Meissner et al., 2008).
The Role of DNA Methylation in the Neural
Commitment and Differentiation of Stem
Cells
Dnmt1, Dnmt3a and Dnmt3b are expressed during CNS
development and differentiation (Feng et al., 2007; Hutnick et al.,
2009). As indicated above, DNA methylation has been shown
to play an important role during embryonic development but
is also significant in the formation of the nervous system as
well as for NSC differentiation (Stroud et al., 2011; Szulwach
et al., 2011; Wu et al., 2011; Chen et al., 2013, 2014). Alterations
in DNA methylation during CNS development are consistent
with the regulation of chromatin-modifying enzymes occurring
during embryonic development (Gapp et al., 2014). For example,
DNMT1 and DNMT3 maintain DNA methylation and regulate
the division of neural progenitor cells and mature neurons
as well as play an important role in adult neurogenesis and
synaptic plasticity of mature neurons. Furthermore, Dnmt1 and
Dnmt3a deletion in mouse forebrain excitatory neurons caused
a decrease in DNA methylation, abnormal neuron size and
dysregulation in expression of genes important for synaptic
plasticity (class I MHC and STAT1). These changes resulted
in dysfunction in long-term plasticity in the hippocampal
CA1 region, and caused learning and memory deficits (Feng
et al., 2010). It was also shown that lack of DNMT1 results in
perturbation of resident populations of neural stem/precursor
cells and post-mitotic neurons. Specifically, the differences were,
respectively, in terms of reduced numbers of neurons and a
reduction of cortical and hippocampal volumes, and a negative
effect on neuronal survival (Noguchi et al., 2015). Moreover
Noguchi et al. (2016) showed that presence of DNMT1 is
essential for hippocampal DG development, given that its lack
in early development leads to poor granule cell layer in the adult
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DG. It was also revealed that during neurogenesis DNMT1 plays
a pivotal role in the regulation of neural differentiation. Such
control of NSC differentiation also serves the purpose of
preventing astrocytes from premature differentiation (Noguchi
et al., 2016).
DNMT3A influences mouse NSC maturation and
differentiation. During neurogenesis, DNMT3A is expressed
in embryonic neural precursor cells (NPCs) within the SVZ
and in postmitotic CNS neurons as well as in oligodendrocytes
(Feng et al., 2005). In order to understand the role of DNMT3A
in NSC differentiation and proliferation, Wu et al. (2012)
used NSC derived from DNMT3A-deficient mouse embryonic
stem cells (ESCs). These Dnmt3a−/− NSCs were globally
hypomethylated and exhibited an increased proliferation rate
compared to control NSCs, which indicates that DNMT3A plays
an important role in mouse NSC proliferation. Moreover, the
same authors observed altered timing of NSC differentiation.
In early passages (P3), Dnmt3a−/− NSCs exhibited precocious
differentiation towards both astrocytes and oligodendrocytes,
while neuronal differentiation was not impaired. Furthermore,
loss of DNMT3A led to an increased number of both astrocytes
and oligodendrocytes (Wu et al., 2012).
During development, neural precursors in the SVZ
give rise to neurons and, subsequently, astrocytes and
oligodendrocytes. This developmental, hierarchical transition
is closely associated with epigenetic remodeling of many
genes. The principal role in astrogliogenesis is played
by Glial Fibrillary Acidic Protein (GFAP) transcription,
which is activated by developmental demethylation of its
promotor. Since the process of GFAP activation is triggered
by STAT3 transcription factor, the methylation of the CpG
at the STAT3 binding site in the GFAP promotor represses
gliogenesis (Takizawa et al., 2001; Feng et al., 2007; Namihira
et al., 2009). These data focused attention to DNA methylation
as a critical determinant of astrocyte differentiation in the
fetal brain.
Recent studies have shown that during the perinatal period,
the male and female mouse brains differ in DNMT enzyme
activity in the highly sexually dimorphic preoptic area (POA).
Exposure to gonadal steroids leads to a decrease in DNMT
activity, which results in a reduction of DNA methylation
(i.e., a reduction of fully methylated CpG sites) and activation
of masculinizing genes. Moreover, DNMT3A inhibition caused
brain masculinization, which resulted in male copulative
behavior. These findings indicated that brain feminization is an
active process maintained by higher levels DNA methylation
(Nugent et al., 2015).
The family of Gadd45 genes is another important player
in CNS development. Candal et al. (2004) have shown that
Gadd45gamma is involved in the development of medaka
fish brain, specifically in cell fate decisions, by affecting cell
cycle exit. Further research demonstrated that, during mouse
neural development, mainly two of Gadd45 genes, Gadd45a and
Gadd45g, are expressed with slight temporospatial differences.
High Gadd45a expression is present in the neural tube during
its closure, in the dorsal root and cranial ganglia VII-X,
and in the olfactory epithelium. Expression of Gadd45g is
also observed in the neural tube, dorsal root and cranial
ganglia VII-X, and olfactory epithelium, but also in neural
precursors, forebrain, midbrain and hindbrain (Kaufmann et al.,
2011).
Furthermore, recent studies have shown that Gadd45b
expression (but not Gadd45a, or Gadd45g) and DNA
methylation in the developing rodent amygdala are different in
individuals of different sexes (Kigar et al., 2016).
Many studies have shown that epigenetic regulation affects
activity-dependent mature brain functions. Activity-dependent
neurogenesis in the adult hippocampus is one of the mechanisms
involved in neural plasticity. However, the specific mechanisms
of action of this phenomenon are poorly understood. Ma et al.
(2009) discovered that Gadd45b is needed for activity-induced
DNA demethylation of some of the gene promoters involved
in adult neurogenesis. Region-specific DNA demethylation,
performed by GADD45B, enabled expression of paracrine
neurogenic niche factors (BDNF, FGF-1, FGF-2) in mature
neurons, which induced activity-dependent adult neurogenesis
(Ma et al., 2009).
Zhou and his group have shown that DNA methylation was
programmed along with neural tube development by the pattern
of appearance of DNA 5mC and 5hmC epigenetic modifications
(Zhou, 2012). They further investigated differences between 5mC
and 5hmC methylation sites in the brain (Chen et al., 2014).
They discovered that 5hmC is located in alternate regions to
5mC, appears at different times during neurodevelopment and
is connected with different MBD proteins. The spatiotemporal
pattern of 5mC and 5hmC DNA methylation sites is closely
associated with the state of differentiation of NSCs in the neural
tube. Appearance of 5hmC is always preceded by the presence of
5mC. It was suggested that the surge of 5mC is connected with
priming of NPCs for differentiation. Additionally, Stroud et al.
(2011) have shown that the timing of 5hmC appearance is closely
related with initiation of neuroepithelial cell differentiation.
5mC and 5hmC reveal different binding partners. While 5mC
preferably binds to MBD1 and MeCP2, 5hmC is associated with
MBD3. Moreover, negative correlation between the amount of
5hmC and MeCP2 levels is observed. 5mC is mostly distributed
in the promoter regions of the genes and is co-localized with
repressive histone marks, H3K9me3 and H3K27me3, while
5hmC is localized in the gene body, downstream from the
transcription start site (TSS) and is co-localized with the
H3K4me2 histone mark, which is a marker of active chromatin
(Stroud et al., 2011). Szulwach et al. (2011) examined 5hmC
occurrence in mouse cerebellum and hippocampus during
neurodevelopment. They found a correlation in the spatial
distribution between 5hmC and NeuN-positive neuronal cells
in the granule cell layer in developing and adult cerebellum,
wherein the amount of 5hmC increased in the latter. In
calbindin-positive Purkinje cells the amount of 5hmC was
increased in both developing and adult cerebellum, compared
to NeuN-positive cells. However, the progenitor cells in the
external granule layer, which are a highly proliferative fraction,
lack 5hmC. In the hippocampus, these authors observed
very low levels or lack of 5hmC in immature (NeuN-
negative) neurons. The amount of 5hmC clearly increased
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in NeuN-positive cells in the DG granule cell layer in both
developing and adult mice. Together, these data suggest that
5hmC clearly appears in mature neuronal cells, which implies
a role in neuronal development (Szulwach et al., 2011). It
is thus suggested that 5hmC is associated with euchromatin
and plays an important role in maintaining the activity of
genes characteristic for specific NSC subtypes (Stroud et al.,
2011; Szulwach et al., 2011; Wu et al., 2011; Chen et al.,
2014).
The most recent studies, using single cell immuno-
identification and cell-specific quantitative methylation assays,
revealed cell-wide DNA de-methylation and subsequent
re-methylation of Purkinje Neurons in the developing
cerebellum (Zhou et al., 2016). This process involved both
5mC and 5hmC. This is the first time when such global
de-methylation has been observed beyond totipotent stages of
development.
The correlation of different MBD proteins with the activated
euchromatin and inactive heterochromatin sites (respectively
MBD1 andMBD3) corresponds to an earlier observation by Zhao
et al. (2003) that the absence of MBD1 causes reduced neuronal
differentiation and increased genomic instability in NSCs and
that adult Mbd1−/− mice exhibit deregulation in the DG of the
hippocampus during adult neurogenesis.
TET (10 to 11 translocation) TET1, TET2 and TET3 proteins
are dioxygenases that catalyze the conversion of the modified
genomic base 5mC into 5hmC and are involved in further
oxidative DNA demethylation process (Tahiliani et al., 2009).
Thus, TET occupancy at gene promoters is negatively correlated
with levels of DNA methylation.
The active participation of TET proteins in neural fate
specification has been the subject of intense investigation given
that in mammals it occurs abundantly in ESCs and neurons
(Wu and Zhang, 2011; Li et al., 2014). Two different lines of
evidence confirmed that non-promotor based 5hmCmethylation
sites are involved in maintaining active chromatin states of
neurogenic genes (Wu et al., 2010; Zhang et al., 2013). It
was first documented that DNMT3A dependent non-proximal
promoter methylation triggers expression of neurogenic genes by
functionally antagonizing Polycomb repression (Wu et al., 2010).
In addition Zhang et al. (2013) have shown TET1 associated
regulation of neural progenitor proliferation in the developing
cortex as well as in a population of adult NSCs.
The precise and dynamic pattern of 5mC and 5hmC
distribution within chromatin as the specific sites of DNA
methylation located either in gene promoters or within the
gene body also raise a more general question regarding
the role of global methylation/demethylation and their link
with the activity of the specific developmental genes. The
mechanism underlying the widely accepted observation that
DNA 5mC methylation at proximal promoters at CpG islands
facilitates silencing of cell type–specific genes, while such
lineage restriction is attenuated when 5hmC methylation
occurs in non-proximal promoters at euchromatic DNA in
of transcriptionally permissive (poised) developmental genes,
remains to be elucidated.
FIGURE 2 | Nucleosome organization and histone post-translational modifications (PTMs).
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HISTONE MODIFICATIONS AND THEIR
RELEVANCE TO STEM CELLS AND
NEURODEVELOPMENT
The structure of the nucleosome and its post-translational
modifications (PTMs) are presented in Figure 2. Nucleosomes
are the basic units of chromatin structure, consisting of DNA
and histones. DNA with a length of 146 bp is wrapped in
1.67 left-handed superhelical turns around an octameric histone
core which comprises a (H3–H4)2 tetramer and two H2A–H2B
dimers. Nucleosomes are joined by 10–50-bp-long stretches of
unwrapped linker DNA and linker histone (H1), which together
are involved in chromatin compaction (Luger et al., 1997;
Richmond and Davey, 2003).
Histones are small alkaline proteins consisting of a
globular C-terminal domain and an N-terminal tail, which
is positively charged and extends outwards from the nucleosome
(Jenuwein and Allis, 2001). Histone tails are highly basic
due to numerous lysine and arginine residues and play an
important role in the structural stability of the nucleosome
and in chromatin compaction. Regulation of the structure of
nucleosomes is possible due to internucleosomal interactions
between N-terminal tails and DNA or other parts of histones
(Arya and Schlick, 2009). There are also sites of numerous
PTMs, such as acetylation, phosphorylation, methylation,
ubiquitination, SUMOylation, ADP-ribosylation, deimination,
proline isomerization, crotonylation and citrullination. Both
chromatin structure and histone modifications affect the
availability of nuclear factors presented to the DNA. PTM can
alter chromatin organization and regulate different processes,
such as DNA replication, chromatin assembly after replication,
transcription or DNA repair processes (Hanks et al., 1983;
Shiio and Eisenman, 2003; Cuthbert et al., 2004; Nelson et al.,
2006; Shogren-Knaak et al., 2006; Kouzarides, 2007; Ismail
et al., 2010; Biswas et al., 2011; Martinez-Zamudio and Ha,
2012; Rothbart and Strahl, 2014). Jenuwein and Allis (2001)
proposed the ‘‘Histone Code Hypothesis’’, suggesting that
different combinations of histone modifications may have
different outcomes and can interact with each other in a
synergistic or antagonistic way. According to this hypothesis,
modification marks on the histone tails should be present and
can be recognized and thus provide binding sites for effector
proteins (Jenuwein and Allis, 2001).
Regulation of Post-Translational
Modifications of Histones
Three main classes of enzymes involved in the PTMs of
histones can be distinguished according to their function:
‘‘writers’’, ‘‘readers’’ and ‘‘erasers’’. Writers are enzymes that
catalyze the addition of methyl, acetyl or other chemical groups
to histone tails, for example Polycomb Repressive Complex
2 (PRC2), SUV39H, DOT1L, with histone methyltransferase
(HMT) activity. Readers are proteins, that are able to recognize
and bind to specific modifications, for example, PRC1, which
reads methylation of H3K27 caused by PRC2 and is subsequently
involved in histone ubiquitinization, or chromodomain helicase
DNA binding protein 1 (CHD1). Erasers are enzymes such as
histone deacetylases (HDACs), or lysine specific demethylase
(LSD; KDM6B), which are involved in the removal of
modifications (Goldberg et al., 2007; Weng et al., 2012). Each
modification may have several writers, readers and erasers
(Kouzarides, 2007).
Over 580 histone regulators from eight model organisms
classified into distinct families have been collected in a large
database1 (Xu et al., 2017). Examples of some compounds
belonging to these three groups are presented in Figure 3.
Histone Acetylation
Histone acetylation is themost well-defined histonemodification
and is linked with the lysine residues on the N-terminal tails
of histones H3 (Lys9, Lys14, Lys18, Lys23) and H4 (Lys5, Lys8,
Lys12, Lys16). During the acetylation process, acetyl groups from
Acetyl-Coenzyme A are transferred to the lysine residues of the
histone N termini. This changes the charge and decreases the
electrostatic interactions between the positively charged histones
and the negatively charged DNA. Furthermore, acetylation of
key lysine residues of the core histones H3 and H4 inhibits
the association of linker histone—H1, which promotes further
chromatin decondensation. This process makes the chromatin
available to transcription factors through its relaxation (Ridsdale
et al., 1990; Lilja et al., 2012). Histone deacetylation, on the other
hand, causes chromatin condensation, preventing binding of
transcription factors to their target sequences in gene promoters
of NSCs resulting in gene suppression (Hsieh and Gage,
2004).
Potentially active euchromatin and inactive heterochromatin
exhibit different acetylation patterns. Euchromatin is normally
acetylated at lysine 5, 8 12 and 16 on histone H4, whereas in
heterochromatin these sites are hypoacetylated (O’Neill and
Turner, 1995). The level of histone acetylation is a dynamic
process and depends on two groups of enzymes; histone
acetyltransferases (HAT), which are capable of activating
acetylation, and HDACs removing this modification, i.e., HDAC
activity. So far, eighteen HDACs have been identified in
mammals. Based on domain organization and sequence
homology with yeast, HDACs can be grouped into four classes
(Table 1). It has been shown that each class has a different
expression pattern. For example, class I HDACs 1, 2, 3, 8 are the
most commonly localized in the nucleus of all cells. On the other
hand, HDAC4, 5, 7 and 9 (class II) are found in both the nucleus
and cytoplasm and exhibit more tissue-specific expression,
suggesting that they are involved in cell differentiation and tissue
specification processes (Haigis and Sinclair, 2010; Lian et al.,
2012; New et al., 2012).
HDAC Complexes as the Regulators of
Histone Acetylation
In mammals, HDACs from class I and II contain two
catalytic domains or form dimers. This suggests that some
proteins require two active centers within the HDACs complex
1http://weram.biocuckoo.org/
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FIGURE 3 | Classification of enzymes involved in the histone PTMs and representative members of each class.
(Zhang et al., 2006). So far, several complexes containing
HDAC1/HDAC2 have been identified.
One of them, the SIN3/HDAC corepressor complex, is
a multiprotein complex implicated in the regulation of key
biological processes such as cell cycle regulation, differentiation,
protein stabilization and destabilization, transcriptional
regulation, cellular senescence or energy metabolism by
deacetylation of histones H3 and H4. The SIN3/HDAC
corepressor complex is comprised of several proteins, including
SIN3 Associated Proteins 30 (SAP30), SAP18, HDAC1, HDAC2,
retinoblastoma binding protein 4 (RBAP4), RBAP7, SDS3,
MeCP2 and Rb-binding protein (RBP1). The modular structure
of the SIN3/HDAC corepressor complex enables different
outcomes depending on the associated proteins (Silverstein
and Ekwall, 2005; Grzenda et al., 2009; Kadamb et al., 2013).
Furthermore, the SIN3/HDAC may also act as a scaffold,
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TABLE 1 | Histone deacetylases classification.
Class Members Localization Description
Class I HDAC1
HDAC2
HDAC3
HDAC8
nucleus
nucleus
nucleus
primarily
nucleus/cytoplasm
– most closely related to the yeast (Saccharomyces cerevisiae)
transcriptional regulator Rpd3;
– they have Zn2+ dependent catalytic domain;
– contains the arginase-like amidino hydrolases;
– ubiquitously expressed in most cell types;
– about 370–500 amino acids;
– HDAC1-3 possess low enzymatic activities when in isolation;
– they may exist in multi-protein repressor complexes in the nucleus
which increase their activity, for instance: SIN3/HDAC corepressor
complex, NuRD, CoREST, NODE, SHIP1;
– HDAC8 is not related with any multi-protein complex, involved in
transcriptional repression;
– HDACs of these class are very important in regulation of
proliferation and in DNA damage response;
Class II II A
II B
HDAC4
HDAC5
HDAC7
HDAC9
HDAC6
HDAC10
nucleus/cytoplasm
nucleus/cytoplasm
nucleus/cytoplasm
nucleus/cytoplasm
primarily cytoplasm
primarily cytoplasm
– class II is divided into two subclasses: IIA and IIB;
– most closely related to the yeast (Saccharomyces cerevisiae)
deacetylase Hda1;
– they have Zn2+ dependent catalytic domain;
– contains the arginase-like amidino hydrolases;
– expression restricted to specific tissues;
– about 1000 amino acids;
– class II alone have little or no deacetylase activity;
– may exist in large protein complexes as, for instance:
HDAC–MEF2 complex, N-CoR, SMRT and BCoR;
– catalytic domains is located in the COOH terminus of the peptide
(exception: HDAC6—contains an internal duplication of two
deacetylase catalytic domains);
– HDAC7 possesses three repression domains;
– HDAC9–many isoforms;
Class III/SIR2 SIRT1
SIRT2
SIRT3
SIRT4
SIRT5
SIRT6
SIRT7
nucleus/cytoplasm
nucleus/cytoplasm
nucleus/mitochondria
mitochondria
mitochondria
nucleus
nucleolus
– belongs to deoxyhypusine synthase (DHS)-like NAD/FAD-binding
domain superfamily;
– related to the yeast silencing protein Sir2 (Silent information
regulator 2);
– SIRT1–6 dependent on NAD+ for enzymatic activity;
– SIRT7 contains putative enzymatic domain;
– from 310 (SIRT4) to 747 (SIRT1) amino acids;
Class IV HDAC11 nucleus/cytoplasm – contains conserved residues in the catalytic core regions shared
by both class I and II of HDACs;
– have Zn2+ dependent catalytic domain;
– contains the arginase-like amidino hydrolases;
– lack of Nuclear Localization Signal (NLS);
– 347 amino acids;
– expression: kidney, heart, brain, skeletal muscle and testis;
– HDAC11 is implicated in immune system regulation via regulation
interleukin-10 expression
enabling access for chromatin remodelers such as histone lysine
methylases and demethylases or transcription factors. In this
manner, SIN3/HDAC may influence chromatin remodeling
processes and transcription regulation (Silverstein and Ekwall,
2005; Grzenda et al., 2009; Kadamb et al., 2013).
Another complex containing HDAC1/HDAC2, the
nucleosome remodeling and deacetylase complex (NuRD),
can act both as nucleosome remodeler and HDAC (Xue
et al., 1998). Additionally, the NuRD complex can play
an important role in the regulation of gene transcription,
DNA repair or maintenance of genome stability. The NuRD
is widely considered to be a transcriptional co-repressor
complex, however some studies indicate that it may also have
a role in the activation of gene expression (Shimbo et al.,
2013). The NuRD complex is formed by several subunits,
inter alia, chromodomain helicase DNA-binding proteins
(CHD3, CHD4, CHD5), histone deacetylases (HDAC1 and
HDAC2), histone binding proteins (RBAP48 and RBAP46),
MBD2, MBD3 and metastasis associated gene 1, 2 and 3
(MTA1, MTA2, MTA3) proteins (Allen et al., 2013). It has
been suggested that heterogeneity of the subunits of this
complex and different combinations of proteins in these
subunits provide unique functional properties (Bowen et al.,
2004).
At least two types of complexes containing histones
deacetylases, namely Co-REST and N-COR, have been shown to
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be involved in the neural commitment and differentiation of stem
cells.
CoREST (co-repressor for element-1-silencing transcription
factor) complex, regulates neuronal gene expression and is
abundantly present in mammalian ESCs, neural progenitors
and differentiated non-neuronal cells. Furthermore, CoREST is
a platform which recruits different epigenetic factors such as
MeCP2, HDAC1/2, LSD1, BHC80 and BRAF35 (Shi et al., 2004;
Ballas et al., 2005).
In mammalian genomes there are three genes coding
the RCOR protein and which form three types of CoREST
complexes: CoREST1, CoREST2 and CoREST3. Recent studies
have shown that each of them exhibits different activity and
function. CoREST3 mostly resembles the CoREST1, however it
has weaker transcriptional repressive activity. CoREST2 exhibits
lower HDAC activity and is not inhibited by HDACs inhibitors
(e.g., SAHA or TSA) like CoREST1 and CoREST3 complexes
(Barrios et al., 2014).
The fourth example of the complex containing HDACs is
the nuclear receptor co-repressor (N-CoR)/silencing mediator
of retinoid and thyroid hormone receptor (SMRT) complex,
comprised of several proteins, including HDAC3, transducin
β-like protein 1 (TBL1)/TBL1-related protein 1 (TBLR1) and
G-protein pathway suppressor 2 (GPS2). It is involved in the
regulation of the differentiation of NSCs and in mouse forebrain
development (Jepsen et al., 2007).
The Relevance of Histone Acetylation for
the Neural Commitment and Differentiation
of Stem Cells
It has been demonstrated that some of the above-mentioned
proteins and complexes play an important role during NSC
differentiation and CNS development.
For example, SKI (transcriptional regulator, present in
progenitor cells and young neurons) level changes during cell
development, while its lack leads to reduced progenitor cell
number and direct differentiation into neurons. The impact
of SKI on neurogenesis may be associated with its ability to
negatively regulate the transforming growth factor β (TGFβ)
and bone morphogenetic protein (BMP) signaling pathways
by binding to SMAD protein complexes. It is postulated that
through its influence on the TGFβ pathway, SKI regulates the
balance between proliferation and differentiation of NPC during
cortical development.
Moreover, SKI interactions with SIN3/HDAC corepressor
complex play an important role during cortical development.
In was demonstrated that SKI is not universally expressed in
whole brain but is present only in proliferating progenitor cells in
the ventricular zone and in subtypes of differentiated projection
neurons of the cortical plate (Luo, 2003; Baranek and Atanasoski,
2012; Baranek et al., 2012).
It was also shown that MBD3 is an important player
during embryonic development. Mbd3−/− ESCs remain in the
pluripotent state and are not able to commit to developmental
lineages (Kaji et al., 2006). Furthermore, NuRD can block
reprogramming of somatic cells into pluripotent stem cells
(Luo, 2003), however, in the presence of NANOG, MBD3/NuRD
induces NSC pluripotency (dos Santos et al., 2014). Such results
indicate a context-dependent manner of MBD3/NuRD role in
facilitating pluripotency and stemness.
CoREST2 complex has been shown to regulate ESC
proliferation and pluripotency (Yang et al., 2011), while
CoREST1 complex plays a significant role during neuronal
differentiation. All CoREST complexes are expressed in the
adult rat brain, both in neuronal and glial cells, however
during neuronal differentiation CoREST1 and CoREST2 are
downregulated, while CoREST3 expression remains unchanged
(Sáez et al., 2015).
It has been shown that CoREST complex stops further
differentiation of neuronal progenitors by repressing neuronal
differentiation genes. The CoREST complex, which has
HDAC activity, interacts with an HMT and this leads to
H3K4 methylation. The simultaneous histone deacetylation
and H3K4 methylation keep neuronal differentiation genes
in a poised state, allowing their further activation. Moreover,
in adult not-neuronal cells, CoREST complex in cooperation
with an H3K4-specific histone LSD1 and H3K9-specific HMT
leads to stable inhibition of neural gene expression (Shi et al.,
2004; Ballas et al., 2005). Interestingly, it has been shown that
CoREST apart from its key role in neuronal differentiation
also influences glial subtype specification and oligodendrocyte
lineage maturation. This is attributed to the influence of
CoREST complex on the expression of glial genes, thus
suggesting that CoREST may be involved in the regulation of
astrocyte and oligodendrocyte function, including modulation
of synaptic plasticity and axonal myelination (Abrajano et al.,
2009). Rodenas-Ruano et al. (2012) demonstrated that in
rat hippocampal neurons, expression of genes that encode
proteins which build subunits of NMDA receptors is also
regulated by REST-dependent DNA methylation. On this
basis, these authors suggest that REST is an important player
involved in experience-dependent activation of genes involved
in synaptic plasticity (Rodenas-Ruano et al., 2012). It has
also been shown that one of the phenotypes of Huntington’s
Disease is correlated with transcriptional misregulations and
abnormal cellular distributions of REST in neurons (Zuccato
et al., 2007).
The CoREST complex together with the LSD1, and the
HDAC1/2 are the main components of the LSD1-CoREST-
HDAC (LCH) transcriptional repressor complexes. Recent
studies revealed that in mammals there are four forms of
LCH, which is associated with alternative splicing isoforms
of LSD1 (LSD1, LSD1-2A, LSD1-8A, LSD1-2A/8A). The
LSD1-8A and LSD1-2A/8A isotypes have been associated with
neuronal differentiation. Moreover, it was shown that different
isoforms are expressed during different stages of neuronal
development. At the beginning of the neuronal differentiation
of rat cortical neurons all LSD1 isoforms are expressed,
however the most abundant ones are LSD1-2A and LSD. In
the subsequent days of differentiation, increasing expression
of LSD1-8A was observed. It was also observed that early-
stage silencing of the LSD1-8A isoform causes a delay in
neurite maturation, which indicates a role in the regulation
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of the proper timing of neurite maturation (Zibetti et al.,
2010).
Furthermore, histone acetylation plays an important
role in both maintenance of ESC pluripotency and neural
differentiation. The histone acetylation level is mostly
regulated by distinct HDAC members, which are expressed
in specific patterns at different neurodevelopmental stages.
Qiao et al. (2015) discovered that H3K9Ac occurs in a very
specific manner during hESC neural differentiation in vitro.
They demonstrated that during the first 4 days of hESC
differentiation, the H3K9Ac level decreased. This is related
to reduced acetylation at several pluripotency genes. Shortly
afterwards, in day 4–8, H3K9Ac levels increased along with
neural differentiation. Furthermore, they showed that the
use of HDAC inhibitors (HDACi) during the first 4 days of
differentiation promoted pluripotency and inhibited neural
commitment (Qiao et al., 2015).
As previously mentioned, PTMs include histone acetylation,
modulate chromatin accessibility and gene expression. Histone
acetylation affects recruitment of chromatin modifier enzymes,
such as bromodomain-containing proteins (BRD). It was shown
that BRDs play a role in ESC self-renewal and development.
For example, both BRD2 and BRD4 mutants are embryonically
lethal. BRD2 null mice embryos exhibit abnormalities in neural
tube development (Shang et al., 2009). Horne et al. (2015)
demonstrated that BRD4 binds at the NANOG promoter and
maintains its expression and is thus critical for the maintenance
of ESC pluripotency.
Different HDACs are expressed at multiple developmental
stages. For example, HDAC1 is highly expressed in mice
NSCs and glia, while HDAC2 expression is present in
neural progenitors and in post-mitotic neurons. Moreover,
HDAC2 expression is absent in most of fully differentiated
glia, suggesting that sequential expression of specific HDACs is
necessary for the differentiation of neuronal and glial subtypes
(MacDonald and Roskams, 2008). Recent studies suggest that
HDAC inhibition influences neurogenesis in the mouse DG by
disturbing the ratio of the neural progenitor types (Foti et al.,
2013). Similarly, HDAC interferes with self-renewal in the SVZ
(Zhou et al., 2011; Foti et al., 2013).
Histone Methylation and its Regulation
Histone methylation is the process whereby methyl groups
are transferred to lysine (K) or arginine (R) residues. Histone
methylation is a reversible process and it is catalyzed by either
HMTs or histone demethylases (HDMs). There are two major
types of HMTs; arginine-specific, catalyzing methylation of
arginine residue on histone H3 and H4, and lysine-specific.
HMTs, which catalyze lysine methylation, are subdivided
into SET domain-containing (e.g., SUV39H1, SUV39H2) and
non-SET domain-containing (e.g., DOT1L; Rea et al., 2000; Feng
et al., 2002).
There are currently two known groups of histone LSDs: a
flavin adenine dinucleotide (FAD)-dependent amine oxidase,
and a Fe(II) and α-ketoglutarate-dependent dioxygenase.
The first group is represented by LSD1 (Lysine-specific
demethylase 1) and the second by the Jumonji domain-
containing proteins (JmjC), which are classified into seven
subgroups (e.g., lysine-specific HDM 5B, KDM5B; Shi et al.,
2004; Tsukada et al., 2006; Li et al., 2014).
Histone methylation may have different outcomes depending
on site (H3 K: 4, 9, 27, 36, 79; H4 K30 or R3) and type of
methylation (mono-, di-, or tri-methylation—me1, me2 or me3).
Methylation of lysine at sites 4, 36 and 79 on histone 3 (H3K4,
H3K36, H3K79) correlates with transcriptional activity and is
most commonly linked to Trithorax Group (TrxG) proteins,
whereas methylation of lysine 9 and 27 on the same histone
(H3K9, H3K27) as well as lysine 20 on histone 4 (H4K20) is
typically associated with gene repression and Polycomb Group
(PcG) proteins (Bernstein et al., 2006; Schuettengruber et al.,
2007).
For example, in housekeeping genes of ESCs there are
marks characteristic for transcription initiation, H3K4me3, while
at developmental genes there are marks typical for active
(H3K4me3) and repressive (H3K27me3) genes, while such
doublemodified genes are generally silent (Bernstein et al., 2006).
The specific state of the chromatin, which presents marks of
activation and inactivation, is described as the ‘‘bivalent’’ state
(‘‘poised state’’; Boheler, 2009).
In vertebrates, the PcG proteins comprise a class of
transcriptional repressors that are found in multi-subunit
complexes. There are two types of Polycomb repressive
complexes: PRC1, which is involved in the maintenance of gene
repression, and PRC2, which is associated with initiation of gene
repression (Rajasekhar and Begemann, 2007). Both complexes
catalyze histone covalent modifications and dynamically
influence cell lineage commitment (Schuettengruber and Cavalli,
2009).
Regulation of developmental activity and pluripotency genes
is linked with activity of the PcG, which binds to the methylated
lysine in position 27 on histone 3 and silencing genes (Scheper
and Copray, 2009). Maherali et al. (2007) suggested that changes
in inactivation marks and PcG play a more significant role for
the reprogramming process than methylation on lysine 4 of
histone 3. Interestingly, during cell differentiation repressive
marks (H3K9me3 and H3K27me3), which in ESCs cover around
4% of the genes, expand to 12%–16% (Hawkins et al., 2010).
The Relevance of Histone Methylation to
the Neural Commitment and Differentiation
of Stem Cells
During CNS development, the differentiation of each type of
progenitor populations is dependent on the activity of various
extracellular signals which facilitate access of transcription
factors to promoters of specific glial or neuronal differentiation
genes. During neural progenitor differentiation into astrocytes,
H3K9 methylation of the GFAP promoter is replaced by
H3K4 methylation. It was demonstrated that during this process
the fibroblast growth factor 2 (FGF2) causes inhibition of
H3K9 methylation and induces H3K4 methylation, which
enables binding of STAT/CBP complex to the STAT binding site
at the promoter ofGFAP and results in gene activation (Song and
Ghosh, 2004). Furthermore, recent studies suggest that histone
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lysine methylation levels are abnormally regulated in the aged
hippocampus, as the baseline resting levels for tri-methylation
of H3K4me3 and acetylation of H3K9, K14Ac were found to
be different in aged rats with memory deficits compared to
those of young adults and failed to increase following object-
learning activity. However, environmental enrichment promoted
object learning in the aged animals suggesting that histone
lysine methylation is implicated in the epigenetic benefits of the
environment on memory function (Morse et al., 2015).
The EZH2 (enhancer of Zeste homolog 2)—HMT, which is a
part of PRC2, represses gene transcription by triple methylation
of lysine 27 (H3K27me3). The PRCs have been widely studied in
mouse ESCs showing that these complexes play an important role
in maintaining pluripotency and regulating cell fate and identity
(de Napoles et al., 2004; Leeb andWutz, 2007; Pereira C. F. et al.,
2010). Furthermore, growing evidence suggests that the PRCs
also play an important role in different aspects of mammalian
development, including the regulation of tissue specific stem
and progenitor cells (Leeb and Wutz, 2010; Laugesen and Helin,
2014).
It has been reported that EZH2, PcG protein, the catalytic
subunit of its PRC2 complex, keeps a balance between cortical
progenitor cell self-renewal and differentiation and affects the
course of neurogenesis (Pereira J. D. et al., 2010). During NSC
differentiation into neurons, expression of EZH2 decreases,
while it is absent when NSC differentiate into astrocytes and
remains at a high level during NSC commitment towards the
oligodendrocytic lineage (Sher et al., 2008). EZH2 was shown
to negatively regulate neuronal induction during mesenchymal
stem cell differentiation by binding to the promoter region
and suppressing expression of PIP5K1C (protein present in
synapses; Yu et al., 2011). Conversely, EZH2 is involved in
suppression of GFAP activation, by binding to its promotor site.
This is mediated by CHD4 acting as a EZH2 partner, where
the dissociation of CHD4 from the PcG is crucial for the onset
of gliogenesis (Sparmann et al., 2013). This suggests a specific
role of EHZ2/CHD4 interaction in PcG repressive complex in
preventing the premature onset of gliogenesis in maintaining the
proper developmental balance in different glial populations.
Furthermore, recent studies have shown that during early
mouse development redistribution of H3K27me3 conducted
by EZH2 takes place and that it coincides with genome-wide
accumulation of H3K9me2, which is mediated by the G9A
enzyme. This histone H3 lysine 9 dimethylation was found
to be crucial for proper development in post-implantation
stage as it regulates the expression of genes involved in
proliferation and cell fate decisions, such as Cd3e, Cdkn1a,
Asz1, Rhox5, Pou5f1. Embryos that lacked G9A, which adds
methyl groups at specific developmentally linked genes and
causes their silencing, exhibited prematurely activated and
inappropriate development. Moreover, G9A enzyme was
found to be important in the mechanisms responsible
for turning off gene expression enhancers (Zylicz et al.,
2015).
Sex-determining region Y-related HMG box 2 (SOX 2) is
an NSC and NPC marker important for their self-renewal
and adult neurogenesis (Graham et al., 2003; Favaro et al.,
2009). SOX2 was shown to be actively involved in epigenetic
regulation of neural development by binding to the promotors
of genes involved in neural differentiation, thus limiting
EZH2 binding and preventing PRC2 activity. It was also shown
that SOX2 is involved in regulating the expression of genes
important during neuronal development, such as neurogenin 2
(Ngn2), neurogenic differentiation 1 (NeuroD1), brain-derived
neurotrophic factor (Bdnf ) and growth arrest-DNA-damage-
inducible beta (Gadd45b). This suggests that SOX2 promotes
an open chromatin state, thus enabling proneural and early
neurogenic gene activation (Amador-Arjona et al., 2015).
Recent evidence suggests that another chromatin component,
Zuotin-related factor 1 (ZRF1), may change developmental gene
expression by displacing the PRC1 complex from chromatin and
is thus involved in cell fate decisions.Moreover, ZRF1 plays a role
in transcriptional regulation and cooperates with deubiquitinase
enzyme (Richly et al., 2010). Taken together, these studies
demonstrate the importance of histone methylation status and
appropriate level of enzymes for the proper development,
function and maintenance of the nervous system.
INTERACTION BETWEEN HISTONE
MODIFICATIONS AND DNA METHYLATION
IN NSC COMMITMENT AND
DIFFERENTIATION
Different histone modifications may interact with DNA
methylation and alter the expression of individual genes.
Laurent et al. (2010) suggested that the level of DNA
methylation is related to local chromatin conformation. Their
findings indicated that there is a strong negative correlation
between the level of DNA methylation and histone marks of
active transcription (H3K4me3). Interaction between DNA
methylation and histone modification is associated with the
occurrence of one of two families of methylated CpG DNA
binding proteins (MBD or BTB/POZ family; Rose and Klose,
2014).
The DNA methylation program as well as the methylation
of histone codes are implicated in neural tube closure during
embryonic development (Zhou, 2012).The link of this process to
the neuronal differentiation was documented by the appearance
of expression of neuronal marks such as NESTIN, CRABP
(Cellular retinoic acid binding protein), NEU-N (Neuronal
Nuclei) and MAP2 (microtubule-associated protein2).
Furthermore, acetylation of histones, together with the
methylation status of DNA play an important role in the
regulation of differentiation of developmental processes by
regulation of tissue-specific genes. Both types of promoters
(high and low-CpG-density promoters) in ESCs are rich in
regions of unmethylated CpGs. However, when ESCs were
differentiated into NPCs, HCP loss of the H3K4me3 mark
caused an increase in the DNA methylation level. Meissner
et al. (2008) discovered that in ESCs HCP of housekeeping
genes are associated with transcription initiation mark on
histone 3 (H3K4me3) and as a consequence, they become highly
expressed. In contrast, HCP of developmental genes are marked
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by both H3K4me3 and H3K27me3 (repressive mark), which
results in their silencing. Moreover, promoters of housekeeping
genes as well as those of developmental genes are tagged
with the H3K4me2 mark, which provides an open chromatin
conformation.
CONCLUSIONS
The epigenetic regulatory mechanisms of DNA methylation and
histone modification are widely involved in reprogramming,
maintaining stemness and NSC differentiation. Epigenome
modifications accompany developmental processes from
the stage of the first embryonic division through stem cell
commitment into defined cell subtypes and determination of
their topographic distribution in the adult brain. Furthermore,
these mechanisms are implicated in basic cellular processes, such
as transcription regulation, DNA replication, cell cycle regulation
and DNA repair. Their failure may thus result in severe
neurodevelopmental pathologies as well as neurodegenerative
diseases. Loss of specific enzymes responsible for deacetylation
is associated with embryo lethality, which confirms their
importance in embryonic development. Methylation and
acetylation are further implicated in cognitive processes such
as learning/plasticity and memory formation. The elucidation
of these mechanisms in the context of epigenetic modifications
may therefore be instrumental for our ability to understand and
influence damage and repair processes in the developing as well
as adult CNS.
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